{"entity":{"type":"insider","cik":"0001745961","url":"/insider/0001745961","json_url":"/insider/0001745961.json","name":"Versant Voyageurs I Parallel, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":77,"n_filings":18,"first":"2020-02-05","last":"2024-08-30","span_basis":"filed_date"},"name_variants":[{"name":"Versant Voyageurs I Parallel, L.P.","source":"filing","n_filings":18,"first_seen":"2020-02-05","last_seen":"2024-08-30"}],"transactions":[{"id":2389239,"accession":"0000950170-24-102354","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-102354","line_url":"/filing/0000950170-24-102354#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":221600.0,"shares_display":"221,600","price_per_share":6.3202,"price_display":"6.32","price_state":"stated","total_value":1400556.32,"total_display":"1,400,556.32","shares_owned_after":3726341.0,"shares_owned_after_display":"3,726,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-28","filed_date":"2024-08-30","scope":"insider"},{"id":6138834,"accession":"0000899243-22-000946","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-22-000946","line_url":"/filing/0000899243-22-000946#line-3","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":null,"owner_name":"Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VII, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600000.0,"shares_display":"600,000","price_per_share":16.0002,"price_display":"16.00","price_state":"stated","total_value":9600120.0,"total_display":"9,600,120.00","shares_owned_after":3623023.0,"shares_owned_after_display":"3,623,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-05","scope":"insider"},{"id":6138831,"accession":"0000899243-22-000946","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-000946","line_url":"/filing/0000899243-22-000946#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":null,"owner_name":"Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VII, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":308000.0,"shares_display":"308,000","price_per_share":16.0002,"price_display":"16.00","price_state":"stated","total_value":4928061.6,"total_display":"4,928,061.60","shares_owned_after":1863197.0,"shares_owned_after_display":"1,863,197","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-05","scope":"insider"},{"id":6138825,"accession":"0000899243-22-000946","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-000946","line_url":"/filing/0000899243-22-000946#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":null,"owner_name":"Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VII, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92000.0,"shares_display":"92,000","price_per_share":16.0002,"price_display":"16.00","price_state":"stated","total_value":1472018.4,"total_display":"1,472,018.40","shares_owned_after":552149.0,"shares_owned_after_display":"552,149","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-05","scope":"insider"},{"id":4306343,"accession":"0000899243-21-034627","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-21-034627","line_url":"/filing/0000899243-21-034627#line-3","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VII, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":510000.0,"shares_display":"510,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":7140000.0,"total_display":"7,140,000.00","shares_owned_after":4223023.0,"shares_owned_after_display":"4,223,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-27","filed_date":"2021-08-31","scope":"insider"},{"id":4306339,"accession":"0000899243-21-034627","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-034627","line_url":"/filing/0000899243-21-034627#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VII, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":261902.0,"shares_display":"261,902","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":3666628.0,"total_display":"3,666,628.00","shares_owned_after":2171197.0,"shares_owned_after_display":"2,171,197","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-27","filed_date":"2021-08-31","scope":"insider"},{"id":4306333,"accession":"0000899243-21-034627","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-034627","line_url":"/filing/0000899243-21-034627#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VII, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78098.0,"shares_display":"78,098","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":1093372.0,"total_display":"1,093,372.00","shares_owned_after":644149.0,"shares_owned_after_display":"644,149","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-27","filed_date":"2021-08-31","scope":"insider"},{"id":2169844,"accession":"0000899243-20-032389","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-20-032389","line_url":"/filing/0000899243-20-032389#line-12","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10193.0,"shares_display":"10,193","price_per_share":33.1286,"price_display":"33.13","price_state":"stated","total_value":337679.8198,"total_display":"337,679.82","shares_owned_after":874299.0,"shares_owned_after_display":"874,299","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-30","filed_date":"2020-12-01","scope":"insider"},{"id":2169840,"accession":"0000899243-20-032389","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-20-032389","line_url":"/filing/0000899243-20-032389#line-11","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":34.1646,"price_display":"34.16","price_state":"stated","total_value":6832.92,"total_display":"6,832.92","shares_owned_after":874099.0,"shares_owned_after_display":"874,099","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-30","filed_date":"2020-12-01","scope":"insider"},{"id":2858129,"accession":"0000899243-20-031918","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-031918","line_url":"/filing/0000899243-20-031918#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":114854.0,"shares_display":"114,854","price_per_share":33.01,"price_display":"33.01","price_state":"stated","total_value":3791330.54,"total_display":"3,791,330.54","shares_owned_after":4818600.0,"shares_owned_after_display":"4,818,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-19","filed_date":"2020-11-23","scope":"insider"},{"id":2858125,"accession":"0000899243-20-031918","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-031918","line_url":"/filing/0000899243-20-031918#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15163.0,"shares_display":"15,163","price_per_share":33.01,"price_display":"33.01","price_state":"stated","total_value":500530.63,"total_display":"500,530.63","shares_owned_after":968954.0,"shares_owned_after_display":"968,954","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-19","filed_date":"2020-11-23","scope":"insider"},{"id":2385485,"accession":"0000899243-20-031771","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-031771","line_url":"/filing/0000899243-20-031771#line-4","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":473.0,"shares_display":"473","price_per_share":33.0938,"price_display":"33.09","price_state":"stated","total_value":15653.3674,"total_display":"15,653.37","shares_owned_after":4933454.0,"shares_owned_after_display":"4,933,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-18","filed_date":"2020-11-19","scope":"insider"},{"id":2385481,"accession":"0000899243-20-031771","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-031771","line_url":"/filing/0000899243-20-031771#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63.0,"shares_display":"63","price_per_share":33.0938,"price_display":"33.09","price_state":"stated","total_value":2084.9094,"total_display":"2,084.91","shares_owned_after":984117.0,"shares_owned_after_display":"984,117","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-18","filed_date":"2020-11-19","scope":"insider"},{"id":2385479,"accession":"0000899243-20-031771","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-031771","line_url":"/filing/0000899243-20-031771#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3705.0,"shares_display":"3,705","price_per_share":33.0498,"price_display":"33.05","price_state":"stated","total_value":122449.509,"total_display":"122,449.51","shares_owned_after":4933927.0,"shares_owned_after_display":"4,933,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-19","scope":"insider"},{"id":2385475,"accession":"0000899243-20-031771","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-031771","line_url":"/filing/0000899243-20-031771#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":489.0,"shares_display":"489","price_per_share":33.0498,"price_display":"33.05","price_state":"stated","total_value":16161.3522,"total_display":"16,161.35","shares_owned_after":984180.0,"shares_owned_after_display":"984,180","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-19","scope":"insider"},{"id":2288331,"accession":"0000899243-20-031322","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-031322","line_url":"/filing/0000899243-20-031322#line-6","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":177.0,"shares_display":"177","price_per_share":33.0125,"price_display":"33.01","price_state":"stated","total_value":5843.2125,"total_display":"5,843.21","shares_owned_after":4937632.0,"shares_owned_after_display":"4,937,632","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-17","scope":"insider"},{"id":2288328,"accession":"0000899243-20-031322","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-20-031322","line_url":"/filing/0000899243-20-031322#line-5","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23.0,"shares_display":"23","price_per_share":33.0125,"price_display":"33.01","price_state":"stated","total_value":759.2875,"total_display":"759.29","shares_owned_after":984669.0,"shares_owned_after_display":"984,669","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-17","scope":"insider"},{"id":2288322,"accession":"0000899243-20-031322","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-031322","line_url":"/filing/0000899243-20-031322#line-4","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2473.0,"shares_display":"2,473","price_per_share":33.3149,"price_display":"33.31","price_state":"stated","total_value":82387.7477,"total_display":"82,387.75","shares_owned_after":4939311.0,"shares_owned_after_display":"4,939,311","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-13","filed_date":"2020-11-17","scope":"insider"},{"id":2288317,"accession":"0000899243-20-031322","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-031322","line_url":"/filing/0000899243-20-031322#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1502.0,"shares_display":"1,502","price_per_share":34.5309,"price_display":"34.53","price_state":"stated","total_value":51865.4118,"total_display":"51,865.41","shares_owned_after":4937809.0,"shares_owned_after_display":"4,937,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-13","filed_date":"2020-11-17","scope":"insider"},{"id":2288309,"accession":"0000899243-20-031322","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-031322","line_url":"/filing/0000899243-20-031322#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":327.0,"shares_display":"327","price_per_share":33.3149,"price_display":"33.31","price_state":"stated","total_value":10893.9723,"total_display":"10,893.97","shares_owned_after":984890.0,"shares_owned_after_display":"984,890","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-13","filed_date":"2020-11-17","scope":"insider"},{"id":2288304,"accession":"0000899243-20-031322","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-031322","line_url":"/filing/0000899243-20-031322#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":198.0,"shares_display":"198","price_per_share":34.5309,"price_display":"34.53","price_state":"stated","total_value":6837.1182,"total_display":"6,837.12","shares_owned_after":984692.0,"shares_owned_after_display":"984,692","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-13","filed_date":"2020-11-17","scope":"insider"},{"id":2732972,"accession":"0000899243-20-031061","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0000899243-20-031061","line_url":"/filing/0000899243-20-031061#line-16","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9450.0,"shares_display":"9,450","price_per_share":34.3928,"price_display":"34.39","price_state":"stated","total_value":325011.96,"total_display":"325,011.96","shares_owned_after":4942137.0,"shares_owned_after_display":"4,942,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-13","scope":"insider"},{"id":2732969,"accession":"0000899243-20-031061","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000899243-20-031061","line_url":"/filing/0000899243-20-031061#line-15","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3976.0,"shares_display":"3,976","price_per_share":33.4774,"price_display":"33.48","price_state":"stated","total_value":133106.1424,"total_display":"133,106.14","shares_owned_after":4951587.0,"shares_owned_after_display":"4,951,587","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-13","scope":"insider"},{"id":2732967,"accession":"0000899243-20-031061","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000899243-20-031061","line_url":"/filing/0000899243-20-031061#line-14","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1248.0,"shares_display":"1,248","price_per_share":34.3928,"price_display":"34.39","price_state":"stated","total_value":42922.2144,"total_display":"42,922.21","shares_owned_after":985264.0,"shares_owned_after_display":"985,264","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-13","scope":"insider"},{"id":2732965,"accession":"0000899243-20-031061","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000899243-20-031061","line_url":"/filing/0000899243-20-031061#line-13","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":524.0,"shares_display":"524","price_per_share":33.4774,"price_display":"33.48","price_state":"stated","total_value":17542.1576,"total_display":"17,542.16","shares_owned_after":986512.0,"shares_owned_after_display":"986,512","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-13","scope":"insider"},{"id":2732963,"accession":"0000899243-20-031061","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000899243-20-031061","line_url":"/filing/0000899243-20-031061#line-12","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":353.0,"shares_display":"353","price_per_share":35.1488,"price_display":"35.15","price_state":"stated","total_value":12407.5264,"total_display":"12,407.53","shares_owned_after":4941784.0,"shares_owned_after_display":"4,941,784","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-13","scope":"insider"},{"id":2732957,"accession":"0000899243-20-031061","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-20-031061","line_url":"/filing/0000899243-20-031061#line-11","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47.0,"shares_display":"47","price_per_share":35.1488,"price_display":"35.15","price_state":"stated","total_value":1651.9936,"total_display":"1,651.99","shares_owned_after":985217.0,"shares_owned_after_display":"985,217","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-12","filed_date":"2020-11-13","scope":"insider"},{"id":2908054,"accession":"0000899243-20-030855","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0000899243-20-030855","line_url":"/filing/0000899243-20-030855#line-8","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9027.0,"shares_display":"9,027","price_per_share":34.9372,"price_display":"34.94","price_state":"stated","total_value":315378.1044,"total_display":"315,378.10","shares_owned_after":5646377.0,"shares_owned_after_display":"5,646,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-12","scope":"insider"},{"id":2908051,"accession":"0000899243-20-030855","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-20-030855","line_url":"/filing/0000899243-20-030855#line-7","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2119.0,"shares_display":"2,119","price_per_share":33.8596,"price_display":"33.86","price_state":"stated","total_value":71748.4924,"total_display":"71,748.49","shares_owned_after":5655404.0,"shares_owned_after_display":"5,655,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-12","scope":"insider"},{"id":2908048,"accession":"0000899243-20-030855","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-030855","line_url":"/filing/0000899243-20-030855#line-6","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1191.0,"shares_display":"1,191","price_per_share":34.9372,"price_display":"34.94","price_state":"stated","total_value":41610.2052,"total_display":"41,610.21","shares_owned_after":987036.0,"shares_owned_after_display":"987,036","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-12","scope":"insider"},{"id":2908045,"accession":"0000899243-20-030855","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-20-030855","line_url":"/filing/0000899243-20-030855#line-5","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":280.0,"shares_display":"280","price_per_share":33.8596,"price_display":"33.86","price_state":"stated","total_value":9480.688,"total_display":"9,480.69","shares_owned_after":988227.0,"shares_owned_after_display":"988,227","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-12","scope":"insider"},{"id":2908042,"accession":"0000899243-20-030855","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-030855","line_url":"/filing/0000899243-20-030855#line-4","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12433.0,"shares_display":"12,433","price_per_share":34.1438,"price_display":"34.14","price_state":"stated","total_value":424509.8654,"total_display":"424,509.87","shares_owned_after":5657523.0,"shares_owned_after_display":"5,657,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-12","scope":"insider"},{"id":2908039,"accession":"0000899243-20-030855","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-030855","line_url":"/filing/0000899243-20-030855#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11388.0,"shares_display":"11,388","price_per_share":33.4778,"price_display":"33.48","price_state":"stated","total_value":381245.1864,"total_display":"381,245.19","shares_owned_after":5669956.0,"shares_owned_after_display":"5,669,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-12","scope":"insider"},{"id":2908036,"accession":"0000899243-20-030855","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030855","line_url":"/filing/0000899243-20-030855#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1642.0,"shares_display":"1,642","price_per_share":34.1438,"price_display":"34.14","price_state":"stated","total_value":56064.1196,"total_display":"56,064.12","shares_owned_after":988507.0,"shares_owned_after_display":"988,507","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-12","scope":"insider"},{"id":2908032,"accession":"0000899243-20-030855","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-030855","line_url":"/filing/0000899243-20-030855#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1503.0,"shares_display":"1,503","price_per_share":33.4778,"price_display":"33.48","price_state":"stated","total_value":50317.1334,"total_display":"50,317.13","shares_owned_after":990149.0,"shares_owned_after_display":"990,149","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-10","filed_date":"2020-11-12","scope":"insider"},{"id":2553289,"accession":"0000899243-20-030745","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-030745","line_url":"/filing/0000899243-20-030745#line-4","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5565.0,"shares_display":"5,565","price_per_share":33.0556,"price_display":"33.06","price_state":"stated","total_value":183954.414,"total_display":"183,954.41","shares_owned_after":5681344.0,"shares_owned_after_display":"5,681,344","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-09","filed_date":"2020-11-10","scope":"insider"},{"id":2553275,"accession":"0000899243-20-030745","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-030745","line_url":"/filing/0000899243-20-030745#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":735.0,"shares_display":"735","price_per_share":33.0556,"price_display":"33.06","price_state":"stated","total_value":24295.866,"total_display":"24,295.87","shares_owned_after":991652.0,"shares_owned_after_display":"991,652","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-09","filed_date":"2020-11-10","scope":"insider"},{"id":2553271,"accession":"0000899243-20-030745","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030745","line_url":"/filing/0000899243-20-030745#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2738.0,"shares_display":"2,738","price_per_share":33.1285,"price_display":"33.13","price_state":"stated","total_value":90705.833,"total_display":"90,705.83","shares_owned_after":5686909.0,"shares_owned_after_display":"5,686,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-06","filed_date":"2020-11-10","scope":"insider"},{"id":2553266,"accession":"0000899243-20-030745","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-030745","line_url":"/filing/0000899243-20-030745#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Vantage I, L.P.; Versant Voyageurs I Parallel, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":362.0,"shares_display":"362","price_per_share":33.1285,"price_display":"33.13","price_state":"stated","total_value":11992.517,"total_display":"11,992.52","shares_owned_after":992387.0,"shares_owned_after_display":"992,387","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-06","filed_date":"2020-11-10","scope":"insider"},{"id":3319914,"accession":"0000899243-20-030580","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-030580","line_url":"/filing/0000899243-20-030580#line-4","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7816.0,"shares_display":"7,816","price_per_share":33.1473,"price_display":"33.15","price_state":"stated","total_value":259079.2968,"total_display":"259,079.30","shares_owned_after":5689647.0,"shares_owned_after_display":"5,689,647","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-05","filed_date":"2020-11-06","scope":"insider"},{"id":3319907,"accession":"0000899243-20-030580","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-030580","line_url":"/filing/0000899243-20-030580#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1032.0,"shares_display":"1,032","price_per_share":33.1473,"price_display":"33.15","price_state":"stated","total_value":34208.0136,"total_display":"34,208.01","shares_owned_after":992749.0,"shares_owned_after_display":"992,749","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-05","filed_date":"2020-11-06","scope":"insider"},{"id":3319904,"accession":"0000899243-20-030580","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030580","line_url":"/filing/0000899243-20-030580#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2208.0,"shares_display":"2,208","price_per_share":33.1357,"price_display":"33.14","price_state":"stated","total_value":73163.6256,"total_display":"73,163.63","shares_owned_after":5697463.0,"shares_owned_after_display":"5,697,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-04","filed_date":"2020-11-06","scope":"insider"},{"id":3319900,"accession":"0000899243-20-030580","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-030580","line_url":"/filing/0000899243-20-030580#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":292.0,"shares_display":"292","price_per_share":33.1357,"price_display":"33.14","price_state":"stated","total_value":9675.6244,"total_display":"9,675.62","shares_owned_after":993781.0,"shares_owned_after_display":"993,781","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-04","filed_date":"2020-11-06","scope":"insider"},{"id":2066757,"accession":"0000899243-20-029546","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-029546","line_url":"/filing/0000899243-20-029546#line-4","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":707.0,"shares_display":"707","price_per_share":33.0325,"price_display":"33.03","price_state":"stated","total_value":23353.9775,"total_display":"23,353.98","shares_owned_after":5699671.0,"shares_owned_after_display":"5,699,671","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-27","filed_date":"2020-10-28","scope":"insider"},{"id":2066754,"accession":"0000899243-20-029546","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-029546","line_url":"/filing/0000899243-20-029546#line-3","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":93.0,"shares_display":"93","price_per_share":33.0325,"price_display":"33.03","price_state":"stated","total_value":3072.0225,"total_display":"3,072.02","shares_owned_after":994073.0,"shares_owned_after_display":"994,073","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-27","filed_date":"2020-10-28","scope":"insider"},{"id":2066752,"accession":"0000899243-20-029546","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-029546","line_url":"/filing/0000899243-20-029546#line-2","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7158.0,"shares_display":"7,158","price_per_share":33.3046,"price_display":"33.30","price_state":"stated","total_value":238394.3268,"total_display":"238,394.33","shares_owned_after":5700378.0,"shares_owned_after_display":"5,700,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-26","filed_date":"2020-10-28","scope":"insider"},{"id":2066751,"accession":"0000899243-20-029546","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-029546","line_url":"/filing/0000899243-20-029546#line-1","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Venture Capital VI, L.P.; Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":945.0,"shares_display":"945","price_per_share":33.3046,"price_display":"33.30","price_state":"stated","total_value":31472.847,"total_display":"31,472.85","shares_owned_after":994166.0,"shares_owned_after_display":"994,166","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-26","filed_date":"2020-10-28","scope":"insider"},{"id":2101818,"accession":"0000899243-20-028811","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-028811","line_url":"/filing/0000899243-20-028811#line-6","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3739.0,"shares_display":"3,739","price_per_share":33.4309,"price_display":"33.43","price_state":"stated","total_value":124998.1351,"total_display":"124,998.14","shares_owned_after":5707536.0,"shares_owned_after_display":"5,707,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-19","filed_date":"2020-10-20","scope":"insider"},{"id":2101816,"accession":"0000899243-20-028811","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-20-028811","line_url":"/filing/0000899243-20-028811#line-5","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":494.0,"shares_display":"494","price_per_share":33.4309,"price_display":"33.43","price_state":"stated","total_value":16514.8646,"total_display":"16,514.86","shares_owned_after":995111.0,"shares_owned_after_display":"995,111","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-19","filed_date":"2020-10-20","scope":"insider"},{"id":2101814,"accession":"0000899243-20-028811","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-028811","line_url":"/filing/0000899243-20-028811#line-4","is_derivative":false,"issuer_cik":"0001687880","issuer_name":"Black Diamond Therapeutics, Inc.","issuer_ticker":"BDTX","issuer_name_source":null,"issuer_url":"/issuer/0001687880","owner_cik":null,"owner_name":"Versant Voyageurs I, L.P.; Versant Voyageurs I Parallel, L.P.; Versant Vantage I, L.P.; Versant Venture Capital VI, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7697.0,"shares_display":"7,697","price_per_share":33.5728,"price_display":"33.57","price_state":"stated","total_value":258409.8416,"total_display":"258,409.84","shares_owned_after":5711275.0,"shares_owned_after_display":"5,711,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-16","filed_date":"2020-10-20","scope":"insider"}],"next_cursor":"2020-10-16|2101814","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001701541","name":"Black Diamond Therapeutics, Inc.","url":"/issuer/0001701541","role":"Ten percent owner","n_filings":16,"first_seen":"2020-02-05","last_seen":"2024-08-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001435049","name":"CHINOOK THERAPEUTICS, INC.","url":"/issuer/0001435049","role":"Ten percent owner","n_filings":2,"first_seen":"2021-08-31","last_seen":"2022-01-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001745961","retrieved_at":"2026-08-21T11:27:10+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}